171 related articles for article (PubMed ID: 20193325)
1. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin].
Chen JF; Jin J
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325
[TBL] [Abstract][Full Text] [Related]
2. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells.
Du YW; Liu GC; Wang J; Zhao YP; Li SL; Chen JG; Jiang Q; Cai J; Ma YF
Ai Zheng; 2009 Feb; 28(2):112-6. PubMed ID: 19550122
[TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor].
Fu YB; Sun QX; Meng FY; Xie J; Zhou GB
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2413-6. PubMed ID: 17156654
[TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
5. [In vitro synergistic effect of bortezomib and pirarubicin on proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells].
Qian ZZ; Wang HQ; Fu K; Ma YL; Hao XS
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):47-51. PubMed ID: 21429402
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
7. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.
Du BY; Song W; Bai L; Shen Y; Miao SY; Wang LF
Chemotherapy; 2012; 58(1):44-51. PubMed ID: 22327308
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
Lashinger LM; Zhu K; Williams SA; Shrader M; Dinney CP; McConkey DJ
Cancer Res; 2005 Jun; 65(11):4902-8. PubMed ID: 15930312
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of bortezomib in inducing apoptosis and improving chemosensitivity of Ishikawa cells].
Shen Y; Hu HY; Lu L
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1301-3, 1309. PubMed ID: 20584662
[TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
14. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].
Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC
Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793
[TBL] [Abstract][Full Text] [Related]
15. [Valproic acid induced intracellular GSH-redox imbalance and apoptosis of leukemic cells resistant to dexamethasone and doxorubicin].
Liu H; Fu RY; Liao QK; Li FY; Zhu YP; Gao J; Mao YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):133-7. PubMed ID: 19292063
[TBL] [Abstract][Full Text] [Related]
16. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma.
Hutter G; Rieken M; Pastore A; Weigert O; Zimmermann Y; Weinkauf M; Hiddemann W; Dreyling M
Ann Hematol; 2012 Jun; 91(6):847-56. PubMed ID: 22231280
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
Duechler M; Linke A; Cebula B; Shehata M; Schwarzmeier JD; Robak T; Smolewski P
Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915
[TBL] [Abstract][Full Text] [Related]
19. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS
Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252
[TBL] [Abstract][Full Text] [Related]
20. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
Zhou RQ; Gong YP; Zheng BH; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]